FDA at the right after approval of the abortion pill

The patience of the anti -abortion movement with the Administration (FDA) of the Food and Drugs (FDA) is thin after the latest approval of the agency after the agency’s latest approval, which is thin after the approval of the second generic version of Myfrisone, one of the two drugs taken for an abortion of a drug.

President Trump repeatedly promised during the campaign last year that he would leave the abortion policy in the states, but anti -abortion lawyers and lawmakers were pushing him forward and limited the availability of the Maffpristone.

So far, that has not happened.

In September, a letter sent to a group of GOP State Attorney Generals confirmed that the FDA was reviewing evidence of Myphstone’s protection to investigate how to be safely distributed.

Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marti Makari wrote in the letter, “September 7,” The administration will confirm that the health of women is properly protected by investigating the circumstances that can be securely distributed. ”

This manifestation has gained some careful optimism from the right, because lawmakers and staff have said they hope that the FDA will soon work to bring back regulatory changes that make Myfrostone easy to access.

But then the news came that Avita Solutions would soon become the third company in the United States to be approved for the production and sale of Myphroston.

“The FDA promised to review the protection below the top-to-top of the chemical abortion, but instead they just greelized its new versions for distribution. I lost confidence in the leadership of the FDA,” Sen Josh Howli (R-M.) wrote on the Social Platform Ex

When asked about Maffprostone during his confirmation hearing, Mackey said that he “The information is a view, ৰ, strictly and meet professional career scientists who have reviewed the data in the FDA and create an expert alliance to review the ongoing data, which needs to be collected.”

In a letter sent to the maker on Friday, Haoli sought specific information about the drug approval process and demanded the Commissioner to explain his personal role in approval.

Hawli writes, “This decision seems to ignore science during the progress of a highly questioned ideological agenda.”

He mentioned that since a possible security change will now come after generic approval, it can be exempted from them.

Hawli writes, “This will render your security review toothless and irrelevant.”

Separately, a group of House Conservatives called Kennedy to dismiss the leaders responsible for ginlight the drug as part of a shutdown-related trim.

“It is clear that the rogue actors in the FDA are working to reduce both the purity of life and the administration’s promise to protect it,” rep. Law makers written by Mark Harris (RNC). “This is why, we respectfully requested that you have considered the Director of the Generic Drugs Office, Director of Drug Drugs and Research Center and other bureaucrats responsible for this reckless decision as part of your decrease-in-for-force evaluation.”

Administration officials defended the decision because they were legally necessary.

The FDA approval means independent of the root and political prejudice of science. They are governed by scientists and other experts, and the drug sponsor is technical and often involves long discussions.

The White House Press Secretary Karoline Levit said on Friday, “This is not the approval of this drug in any way. They are just following the law.” “By law, the Secretary of the Department of Health and Human Services must approve a generic drug application if the application considers the drug ‘the same’ as a brand-name drug.”

To this day, the White House initially attacked low-lying fruits on abortion.

The administration reduces funding for family planning and returns the biden era policy on urgent access to abortion, but it has not yet taken big steps to reduce access.

Sixteen states are almost banned on abortion. Nevertheless, abortion is still an alternative for people living there due to the availability of abortion drugs. Physicians in the protected state of the abortion are determining Myphristone via telehews and then sending the pills to the mail.

This effort has introduced legal challenges on the “Shield Law” that protects these physicians from the case in a state where abortion is banned.

Anti-pregnant groups want the FDA, at the minimum, re-establish strict rules that forbid the sending of Maffprstone to mail. The Biden administration was behind them during the Covid -19 epidemic.

“President Trump believes that the state has the right to pass and enforce the life-supporter of the state. Yet this right is being trapped by abortion industry every day,” the anti-abortion group Susan B. The anthony America said in a statement.

The group’s state public affairs director Kelsi Pritchard said there was no reason to wait for the FDA. He said that the protection review should be a priority, but the administration should bring back the fixed requirements.

“We need FDA to change the course. Fast,” Pritchard said.

Pritchard said that the approval of the Second Generic Mifistone did not integrate with the priorities described in the administration.

“It’s not Maga, it’s not great” he said. “It never heals America again.”

Life of America student spokesman Christie Hamric said he understood the “feelings of lawyers who called for a change in the FDA.”

In a text message, Hamric told The Hill, “We need more than assurance on social media.”

Hamric said, “We are looking for scente discussions and symptoms that the work is being completed. The work is being completed. The Trump administration has taken a basis for all kinds of issues in the government. And it needs to include chemical abortion pills,” said Hamric.

The Students for Life were part of an anti -abortion lawyer, state lawmakers, physicians and religious leaders, against the latest approval of the FDA on Friday and calling for removal from the market.

They wrote, “This approval has been directly opposed to the recent public assurance of Secretary Kennedy that the protection of the abortion drugs was questionable and will be fully reviewed,” they wrote.